Similar Items: Elucidating the underlying mechanisms of benfotiamine-induced cardioprotection
- Possible mechanisms for levosimendaninduced cardioprotection
- Novel therapeutic agents that blunt hyperglycemia-induced cardiac contractile dysfunction
- Anthracycline-induced cardiotoxicity : the role of proteolytic pathways
- Hyperglycemia-mediated onset of myocardial insulin resistance – unraveling molecular mechanisms and identifying therapeutic targets
- Prevalence of Occlusive Myocardial Infarction (OMI) in patients diagnosed with Non-ST-Elevation Myocardial Infarction (NSTEMI) at a single private facility in Cape Town, South Africa, during 2019
- Prevalence of Occlusive Myocardial Infarction (OMI) in patients diagnosed with Non-ST-Elevation Myocardial Infarction (NSTEMI) at a single private facility in Cape Town, South Africa, during 2019
Author: Essop, M. Faadiel
- TKTL1 plays a critical role in ameliorating intracellular oxidative stress under hyperglycemic conditions
- Establishing a rodent model of long-term consumption of sugar-sweetened beverages
- Leukocyte O-GlcNAcylation : a novel diagnostic tool for the earlier detection of type 2 diabetes mellitus?
- Establishing and validating an in vivo rodent model of chronic restraint stress
- Elucidating the underlying mechanisms of benfotiamine-induced cardioprotection
- Novel therapeutic agents that blunt hyperglycemia-induced cardiac contractile dysfunction